_id
6913142dccc777a4e85d7fe3
Ticker
MDCX
Name
Medicus Pharma Ltd. Common Stock
Exchange
OTCBB
Address
300 Conshohocken State Road, Conshohocken, PA, United States, 19428
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
USD
Website
https://medicuspharma.com
Description
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.
Last Close
1.53
Volume
175557
Current Price
1.55
Change
0.07
Last Updated
2026-01-05T10:16:22.676Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
40067276
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.33
Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
15426340
Operating Income
-15426340
Interest Expense
-
Pretax Income
-15981312
Net Income
-15981312
Eps
-0.7620628023622198
Dividends Per Share
-
Shares Outstanding
24709144
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-566544
Cash
8662091
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
9781412
Property Plant Equipment
196249
Total Assets
9977661
Payables
2027509
Short Term Debt
-
Long Term Debt
29462
Total Liabilities
10782551
Equity
-910126
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-1336539
Cash From Operations
-6757829
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
10371267
Net Change In Cash
-1007455
Cf_currency_symbol
USD
PE
-
PB
-35.71509779964532
ROE
1755.9450010218366
ROA
-160.17092583121436
FCF
-6757829
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
1.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
5.5
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
15426340
Quarters > 0 > income Statement > operating Income
-15426340
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-15981312
Quarters > 0 > income Statement > net Income
-15981312
Quarters > 0 > income Statement > eps
-0.7620628023622198
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
20971122
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-566544
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
8662091
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
9781412
Quarters > 0 > balance Sheet > property Plant Equipment
196249
Quarters > 0 > balance Sheet > total Assets
9977661
Quarters > 0 > balance Sheet > payables
2027509
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
29462
Quarters > 0 > balance Sheet > total Liabilities
10782551
Quarters > 0 > balance Sheet > equity
-910126
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-15981312
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-1336539
Quarters > 0 > cash Flow > cash From Operations
-6757829
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
10371267
Quarters > 0 > cash Flow > net Change In Cash
-1007455
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.7620628023622198
Quarters > 0 > ratios > PB
-35.71509779964532
Quarters > 0 > ratios > ROE
1755.9450010218366
Quarters > 0 > ratios > ROA
-160.17092583121436
Quarters > 0 > ratios > FCF
-6757829
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
6016088
Quarters > 1 > income Statement > operating Income
-6016088
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-6176084
Quarters > 1 > income Statement > net Income
-6176084
Quarters > 1 > income Statement > eps
-0.38754900300986445
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
15936266
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-200000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
9669546
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
10996731
Quarters > 1 > balance Sheet > property Plant Equipment
220999
Quarters > 1 > balance Sheet > total Assets
11934628
Quarters > 1 > balance Sheet > payables
1770178
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
8685918
Quarters > 1 > balance Sheet > equity
3248710
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-6176080
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
253988
Quarters > 1 > cash Flow > cash From Operations
-5468831
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
11155947
Quarters > 1 > cash Flow > net Change In Cash
5687116
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.38754900300986445
Quarters > 1 > ratios > PB
7.603390976726147
Quarters > 1 > ratios > ROE
-190.10881242093015
Quarters > 1 > ratios > ROA
-51.74927949157695
Quarters > 1 > ratios > FCF
-5468831
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
21
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
5126274
Quarters > 2 > income Statement > operating Income
-5126274
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-5102408
Quarters > 2 > income Statement > net Income
-5102408
Quarters > 2 > income Statement > eps
-0.380278353122449
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
13417561
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3982430
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
5087775
Quarters > 2 > balance Sheet > property Plant Equipment
245091
Quarters > 2 > balance Sheet > total Assets
5657866
Quarters > 2 > balance Sheet > payables
2035364
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3510312
Quarters > 2 > balance Sheet > equity
2147554
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-5102410
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
1025657
Quarters > 2 > cash Flow > cash From Operations
-3940994
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
3759101
Quarters > 2 > cash Flow > net Change In Cash
-181893
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.380278353122449
Quarters > 2 > ratios > PB
9.684142773592654
Quarters > 2 > ratios > ROE
-237.5916042157729
Quarters > 2 > ratios > ROA
-90.18255292719905
Quarters > 2 > ratios > FCF
-3940994
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
25
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
2350705
Quarters > 3 > income Statement > operating Income
-2350705
Quarters > 3 > income Statement > interest Expense
796110
Quarters > 3 > income Statement > pretax Income
-2274581
Quarters > 3 > income Statement > net Income
-2274581
Quarters > 3 > income Statement > eps
-0.19248833919324998
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
11816721
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
4164323
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5378307
Quarters > 3 > balance Sheet > property Plant Equipment
268571
Quarters > 3 > balance Sheet > total Assets
5646878
Quarters > 3 > balance Sheet > payables
1284612
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2512174
Quarters > 3 > balance Sheet > equity
3134704
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2274580
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-1102656
Quarters > 3 > cash Flow > cash From Operations
-3267155
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2125319
Quarters > 3 > cash Flow > net Change In Cash
-1141836
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.19248833919324998
Quarters > 3 > ratios > PB
5.842949621399661
Quarters > 3 > ratios > ROE
-72.56126894277737
Quarters > 3 > ratios > ROA
-40.280328351347414
Quarters > 3 > ratios > FCF
-3267155
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
11180902
Annuals > 0 > income Statement > operating Income
-11180902
Annuals > 0 > income Statement > interest Expense
902362
Annuals > 0 > income Statement > pretax Income
-11155516
Annuals > 0 > income Statement > net Income
-11155516
Annuals > 0 > income Statement > eps
-0.9440449681430237
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
11816721
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
238517
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
4164323
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5378307
Annuals > 0 > balance Sheet > property Plant Equipment
268571
Annuals > 0 > balance Sheet > total Assets
5646878
Annuals > 0 > balance Sheet > payables
1284612
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2512174
Annuals > 0 > balance Sheet > equity
3134704
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-11155516
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
32927
Annuals > 0 > cash Flow > cash From Operations
-10247231
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
12692216
Annuals > 0 > cash Flow > net Change In Cash
2444985
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.9440449681430237
Annuals > 0 > ratios > PB
6.031431867251262
Annuals > 0 > ratios > ROE
-355.8714315610023
Annuals > 0 > ratios > ROA
-197.5519216104899
Annuals > 0 > ratios > FCF
-10247231
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
2658365
Annuals > 1 > income Statement > operating Income
-2658365
Annuals > 1 > income Statement > interest Expense
739096
Annuals > 1 > income Statement > pretax Income
-5314765
Annuals > 1 > income Statement > net Income
-5314765
Annuals > 1 > income Statement > eps
-0.6580340910160198
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
8076732
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-2071580
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1719338
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1893057
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
1893057
Annuals > 1 > balance Sheet > payables
210842
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
781609
Annuals > 1 > balance Sheet > equity
1111448
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-6784140
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
473096
Annuals > 1 > cash Flow > cash From Operations
-4158264
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
5609950
Annuals > 1 > cash Flow > net Change In Cash
1451686
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.6580340910160198
Annuals > 1 > ratios > PB
11.626968783064974
Annuals > 1 > ratios > ROE
-478.1838646522375
Annuals > 1 > ratios > ROA
-280.7503947319072
Annuals > 1 > ratios > FCF
-4158264
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
978416
Annuals > 2 > income Statement > operating Income
-978416
Annuals > 2 > income Statement > interest Expense
526825
Annuals > 2 > income Statement > pretax Income
-1692382
Annuals > 2 > income Statement > net Income
-1692382
Annuals > 2 > income Statement > eps
-0.21026403549728023
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
8048842
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
388306
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
267652
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
282652
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
282652
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
12480684
Annuals > 2 > balance Sheet > equity
-12198032
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-1692382
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
-78687
Annuals > 2 > cash Flow > cash From Operations
-1057103
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
1246241
Annuals > 2 > cash Flow > net Change In Cash
189138
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.21026403549728023
Annuals > 2 > ratios > PB
-1.0557561416464558
Annuals > 2 > ratios > ROE
13.874221677726375
Annuals > 2 > ratios > ROA
-598.7511144446173
Annuals > 2 > ratios > FCF
-1057103
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
25
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
1441388
Annuals > 3 > income Statement > operating Income
-1441388
Annuals > 3 > income Statement > interest Expense
115406
Annuals > 3 > income Statement > pretax Income
-2055263
Annuals > 3 > income Statement > net Income
-2055263
Annuals > 3 > income Statement > eps
-0.2553489060910874
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
8048842
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
76978
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
78514
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
78514
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
78514
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
10584164
Annuals > 3 > balance Sheet > equity
-10505650
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-2055263
Annuals > 3 > cash Flow > depreciation
-
Annuals > 3 > cash Flow > change In Working Capital
-6658
Annuals > 3 > cash Flow > cash From Operations
-1448046
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
882385
Annuals > 3 > cash Flow > net Change In Cash
-565661
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.2553489060910874
Annuals > 3 > ratios > PB
-1.225830595917435
Annuals > 3 > ratios > ROE
19.563406357531424
Annuals > 3 > ratios > ROA
-2617.7025753368825
Annuals > 3 > ratios > FCF
-1448046
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.7620628023622198
Valuation > metrics > PB
-35.71509779964532
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
1755.9450010218366
Profitability > metrics > ROA
-163.38450931215246
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-27.22884718574374
Risk > final Score
-79
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.824349485008451
Liquidity > metrics > Quick Ratio
4.824349485008451
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
21.570503786003393
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-102
Prev Risks > 1
50
Prev Risks > 2
36
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:11:24.799Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.12
Earnings History > 0 > eps Estimate
-0.22
Earnings History > 0 > eps Difference
-0.9
Earnings History > 0 > surprise Percent
-409.0909
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.43
Earnings History > 1 > eps Estimate
-0.25
Earnings History > 1 > eps Difference
-0.18
Earnings History > 1 > surprise Percent
-72
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.42
Earnings History > 2 > eps Estimate
-0.215
Earnings History > 2 > eps Difference
-0.205
Earnings History > 2 > surprise Percent
-95.3488
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.14
Earnings History > 3 > eps Estimate
-0.315
Earnings History > 3 > eps Difference
0.175
Earnings History > 3 > surprise Percent
55.5556
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-27
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.31
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.31
Earnings History > 4 > surprise Percent
-
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AInsider Trends: Why is KUKE stock going up - Market Sentiment Summary & Weekly Top Gainers Alerts baoquankhu1.vn
Read more →Medicus Pharma Rings Nasdaq Opening Bell to Celebrate One-Year Listing Anniversary - Intellectia AI
1/20/2026
Medicus Pharma Rings Nasdaq Opening Bell to Celebrate One-Year Listing Anniversary Intellectia AI
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Medicus Pharma Ltd. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.12
EPS Estimate
-0.22
EPS Difference
-0.9
Surprise Percent
-409.0909%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.